课题基金 / 基金详情

Gene regulation and cell differentiation of FGF8

Gene regulation and cell differentiation of FGF8
FGF8的基因调控和细胞分化
批准号:
09670235
负责人:
TANAKA Akira
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

TANAKA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
1.Fgf8基因调控特性Fgf8基因的启动子在300b.p。位于5‘侧翼的区域。在10 nM睾酮存在下,其启动子活性不受影响。此外,各种报告结构,包括内含子和3‘-区,在Fgf8基因中没有显示任何雄激素反应区域。雄激素非依赖性志诺木癌细胞分泌生长因子的分离:由于激活素结合蛋白-卵泡抑素完全阻断了刺激生长的事实,并且在部分纯化的组分中发现了具有抗激活素βA和βB抗体的免疫活性物质,因此该分泌的生长因子最终被鉴定为激活素。激活素在雄激素不敏感的人前列腺癌PC-3细胞中也有明显的表达,但在雄激素敏感的LNCaP细胞中很少表达,这表明激活素的表达与激素不敏感的生长条件有关。FGF8在人类肿瘤和小鼠胚胎中的表达:利用我们新建立的抗小鼠和人FGF8的中和性单抗,用免疫组织化学方法检测了不同标本中FGF8的表达。在人类癌症标本中,FGF8在前列腺癌中频繁表达,但在前列腺增生症中不表达。在小鼠胚胎中,FGF8在分化的神经细胞中有较强的表达。此外,FGF8还能促进培养的大鼠嗜铬细胞瘤PC12细胞突起的生长。
英文摘要
1. Characterization of fgf8 gene regulation The promoter of the fgf8 gene was found within 300 b.p. of the 5'-flanking region. Its promoter activity was not affected in the presence of 10 nM testosterone. In addition, various reporter constructs, including the introns and the 3'-region, failed to show any androgen-responsive region in the fgf8 gene.2. Isolation of a growth factor secreted from androgen-independent Shionogi carcinoma cells: The secreted growth factor was finally identified as activin from the facts that the stimulated growth is completely blocked by activin-binding protein, follistatin, and that immunoreactive substances with anti-activin βA and βB antibodies are found in the partially purified fractions. Activin expression was also marked in androgen-insensitive human prostate cancer PC-3 cells, but, scarce in androgen-sensitive LNCaP cells, suggesting that activin expression is correlated with hormone-unresponsive growth condition.3. FGF8 expression in human cancers and murine embryos: By use of our newly established neutralizing monoclonal antibody against murine and human FGF8, expression of FGF8 in various specimens was immunohistochemically examined. In human cancer specimens, FGF8 was frequently expressed in prostate cancers, but, not in prostate hyperplasias. In murine embryos, FGF8 was strongly expressed in differentiated neuronal cells. In addition, FGF8 had ability to promote neurite extension in cultured rat pheochromacytoma PC12 cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tanaka,A.et al: "High frequency of fibroblast growth factor(FGF)8 expression in clinical prostate cancers and breast tissues,Immunohistrochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF8" Cancer Research. 58. 205
Tanaka,A.等人:“临床前列腺癌和乳腺组织中成纤维细胞生长因子 (FGF)8 的高频率表达,通过新建立的针对 FGF8 的中和单克隆抗体进行免疫组织化学证明”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka, A. et al: "High frequency of fibroblast growth factor(FGF)8 expression in clinical prostate cancer and breast fissures immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF"Cancer Research. 58. 2053
Tanaka, A. 等人:“通过新建立的针对 FGF 的中和单克隆抗体,免疫组织化学证明了临床前列腺癌和乳腺裂隙中成纤维细胞生长因子 (FGF)8 的高频率表达”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mathematical Analyses on Sampling Theorems in Reproducing Kernel Hilbert Spaces
  • 批准号:
    24500001
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    TANAKA Akira
  • 依托单位:
The evaluation method for the effect of the various unnatural video components on viewers using physiological indices.
  • 批准号:
    23500146
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    TANAKA Akira
  • 依托单位:
Development of the diet therapy considering polymorphisms of metabolic syndrome related gene
  • 批准号:
    21500794
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2009
  • 负责人:
    TANAKA Akira
  • 依托单位:
Mathematical Properties of Sampling and Optimal Reproducing Kernels
  • 批准号:
    21700001
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.75万
  • 财政年份:
    2009
  • 负责人:
    TANAKA Akira
  • 依托单位:
国内基金
海外基金
Activin A诱导单核来源的朗格汉斯细胞在皮肤黑素瘤早期免疫抑制微环境形成中的作用及机制研究
  • 批准号:
    JCZRYB202500430
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肾衰营养胶囊通过Activin A调节肾-骨 骼肌交互轴改善CKD-PEW的作用及机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    胡蓉
  • 依托单位:
Activin/Nodal通路在人类髓系祖细胞发育路径中的作用及其机制研究
  • 批准号:
    32400604
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    刘晶晶
  • 依托单位:
SNORA14A/MT2A抗氧化轴失调介导Activin-A表达增加促进肝母细胞瘤进展的机制及临床价值研究
  • 批准号:
    82302615
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    朱佳蓓
  • 依托单位: